Flotek Industries, Inc. (NYSE:FTK) raised its full-year 2026 revenue and Adjusted EBITDA guidance, citing higher-than-expected international chemistry sales.
The Houston-based company now expects total revenue of between $360 million and $370 million for 2026, compared with its previous guidance range of $340 million to $350 million issued on August 4.
Adjusted EBITDA is forecast at between $50 million and $54 million, up from the previous range of $47 million to $51 million.
At the midpoints of the revised guidance ranges, Flotek said revenue and Adjusted EBITDA would increase by 54% and 58%, respectively, compared with reported full-year 2025 results.
International chemistry sales increase in second quarter
Flotek reported international chemistry revenue of approximately $10.6 million in the second quarter of 2026, representing a sequential increase of more than 450% from the first quarter.
The company said international chemistry sales could exceed $40 million during the second half of the year, supported in part by ongoing activity in Saudi Arabia.
“We have continued to experience growing demand, in particular in international chemistry, since increasing our 2026 guidance last month, giving us the confidence to further increase our outlook for the year,” Chief Executive Officer Dr. Ryan Ezell said.
Adjusted EBITDA guidance increases
Flotek reported Adjusted EBITDA of $32.8 million for the year ended December 31, 2025, according to a reconciliation table included with the company’s announcement.
The company said it could not reconcile its forward-looking Adjusted EBITDA guidance to GAAP net income without unreasonable effort because of uncertainties involving items including stock-based compensation and borrowing costs.
Flotek is scheduled to participate in the Lake Street Annual Investor Conference in New York on September 10, where Ezell is expected to hold investor meetings.
Flotek Industries stock price
